Comparative bioavailability of betahistine tablet formulations administered in healthy subjects

Arzneimittel-Forschung/Drug Research

Volumn 60, Issue 7, 2010, Pages 440-444

  Val, Ligia ^a   Chen, Lu Shi ^c   Mendes, Gustavo Duarte ^a,d   De Nucci, Gilberto ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c Galeno Research Unit   (Brazil)

^d Universidade Castelo Branco   (Brazil)

Author keywords

2 Pyridylacetic acid; Betahistine, bioequivalence, pharmacokinetics; CAS 5579 84 0; LC MS MS

Indexed keywords

2 PYRIDYLACETIC ACID; ACETIC ACID DERIVATIVE; BETAHISTINE; LABIRIN; UNCLASSIFIED DRUG; 2-PYRIDYLACETIC ACID; PYRIDINE DERIVATIVE; TABLET; VASODILATOR AGENT;

ACCURACY; ADULT; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM; DRUG DOSAGE FORM COMPARISON; DRUG STABILITY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; LIQUID CHROMATOGRAPHY; MALE; POSITIVE ION ELECTROSPRAY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TABLET FORMULATION; TANDEM MASS SPECTROMETRY; ADOLESCENT; AREA UNDER THE CURVE; BIOAVAILABILITY; BLOOD; HALF LIFE TIME; MIDDLE AGED; REFERENCE VALUE; TABLET;

ACETATES; ADOLESCENT; ADULT; AREA UNDER CURVE; BETAHISTINE; BIOLOGICAL AVAILABILITY; FEMALE; HALF-LIFE; HUMANS; MALE; MIDDLE AGED; PYRIDINES; REFERENCE VALUES; TABLETS; VASODILATOR AGENTS;

EID: 77955391801     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296309     Document Type: Article

References (8)

1. Barak N. Betahistine: what's new on the agenda? Expert Opin Investig Drugs. 2008;17(5):795-804.
2. Botta L, Mira E, Valli S, Zucca G, Benvenuti C, Fossati A, et al. Effects of betahistine and of its metabolites on vestibular sensory organs. Acta Otorhinolaryngol Ital. 2001;21(66):24-30.
3. Chen XY, Zhong DF, Duan JL, Yan BX. LC-MS-MS analysis of 2-pyridylacetic acid, a major metabolite of betahistine: application to a pharmacokinetic study in healthy volunteers. Xenobiotica. 2003;33(12):1261-71.
4. Curwain BP, Holton P, Spencer J. The effect of betahistine on gastric acid secretion and mucosal blood flow in conscious dogs. Br J Pharmacol. 1972;46(2):351-4.
5. Douglas JF, Hohing TL. GLC determination of betahistine in serum. Experientia. 1978;34(4):499-500.
6. Food and Drug Administration. Bioavailability and Bioequivalence Studies for Orally Administered Drug Products - General Considerations; 2003.
7. Fossati A, Barone D, Benvenuti C. Binding affinity profile of betahistine and its metabolites for central histamine receptors of rodents. Pharmacol Res. 2001;43(4):389-92.
8. Lacour M, Sterkers O. Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action. CNS Drugs. 2001;15(11):853-70.